Related Experiment Video

Updated: Aug 25, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Rho GTPases: potential candidates for anticancer therapy

Salvador Aznar1, Pilar Fernández-Valerón, Carolina Espina

  • 1Department of Molecular and Cellular Biology of Cancer, Instituto de Investigaciones Biomédicas, CSIC, Arturo Duperier 4, Madrid 28029, Spain.

Cancer Letters
|March 12, 2004
PubMed

Insights

Rho GTPases regulate crucial cell functions. Targeting these proteins offers new therapeutic strategies for cancer, impacting tumor growth and metastasis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Rho GTPases are key regulators of cellular processes including proliferation, migration, and apoptosis.
  • Overexpression of Rho GTPases is frequently observed in human tumors, implicating them in carcinogenesis.
  • Understanding Rho GTPase signaling pathways is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To review the biological functions of Rho GTPases in tumor biology.
  • To summarize recent advancements in understanding Rho GTPase downstream effectors and transcription factors in tumorigenesis.
  • To describe novel drugs targeting Rho signaling with antineoplastic and antimetastatic potential.

Main Methods:

  • Literature review of Rho GTPase functions in cancer.
  • Analysis of downstream effectors and transcription factors involved in Rho-mediated tumorigenesis.
  • Compilation of data on targeted therapeutic agents affecting Rho signaling.

Main Results:

  • Rho GTPases control fundamental cellular processes critical for tumor cell proliferation and motility.
  • Aberrant Rho signaling contributes significantly to tumor development and metastasis.
  • Specific drugs targeting Rho signaling pathways have demonstrated antineoplastic and antimetastatic efficacy.

Conclusions:

  • Rho GTPases are pivotal in cancer progression, making them attractive therapeutic targets.
  • Targeted interventions in Rho signaling pathways hold promise for effective cancer treatment.
  • Further research into Rho GTPase biology and targeted therapies can lead to improved patient outcomes.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.